PureFunds ETFx HealthTech ETF IMED 深 沪
等待开盘 03-26 09:30:00 美东时间
28.96
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 28.96
- 总市值 290.00万
- 52周最高 56.28
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 23.16
- 委 比 0.00%
- 总股本 10.01万
- 历史最高 56.28
- 量 比 0
- 振 幅 0.00%
- 历史最低 23.16
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board
BRIEF-Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board March 25 (Reuters) - Apimeds Pharmaceuticals US Inc APUS.A : APIMEDS PHARMACEUTICALS - APPOINTS YOUNGJIK CHO AS CHAIRMAN OF THE BOARD - SEC FILING APIMEDS PHARMACEUTICALS- ON MAR 20, REMOVES ELONA KOGAN, JAKAP KOO, CAROL O'DONN
03-25 19:20
BRIEF-Apimeds Pharmaceuticals Us Inc. Announces Material Breach Of Merger Agreement By Inscobee Inc And Apimeds Inc
BRIEF-Apimeds Pharmaceuticals Us Inc. Announces Material Breach Of Merger Agreement By Inscobee Inc And Apimeds Inc March 24 (Reuters) - Apimeds Pharmaceuticals US Inc APUS.A : APIMEDS PHARMACEUTICALS US INC. ANNOUNCES MATERIAL BREACH OF MERGER AGREEMENT BY INSCOBEE INC. (KS:006490) AND APIMEDS INC.
03-24 20:38
BRIEF-Fujikura Ltd - To Increase Optical Fiber Production Capacity In Japan And U.S., Investing Maximum 300 Billion Yen
BRIEF-Fujikura Ltd - To Increase Optical Fiber Production Capacity In Japan And U.S., Investing Maximum 300 Billion Yen March 13 (Reuters) - Fujikura Ltd 5803.T : FUJIKURA LTD - TO PROCEED WITH CAPITAL INVESTMENT AIMED AT EXPANDING PRODUCTION CAPACITY FOR THE OPTICAL FIBER AND OPTICAL FIBER CABLE FU
03-13 13:05
BRIEF-Kairos Pharma Announces Signing Of Binding Strategic Asset Acquisition Of Exclusive Worldwide Rights To Cl-273 From Orbimed And Torrey Pines Investment-Backed Celyn Therapeutics
BRIEF-Kairos Pharma Announces Signing Of Binding Strategic Asset Acquisition Of Exclusive Worldwide Rights To Cl-273 From Orbimed And Torrey Pines Investment-Backed Celyn Therapeutics March 2 (Reuters) - Kairos Pharma Ltd KAPA.A : KAIROS PHARMA ANNOUNCES SIGNING OF BINDING STRATEGIC ASSET ACQUISITIO
03-02 22:11
BRIEF-ASP Isotopes Says QLE & NECSA Advance Collaboration for Production Of HALEU Nuclear Fuel
BRIEF-ASP Isotopes Says QLE & NECSA Advance Collaboration for Production Of HALEU Nuclear Fuel Feb 23 (Reuters) - ASP Isotopes Inc ASPI.O : JSE: ISO - ASPI ANNOUNCES QLE AND NECSA ADVANCE STRATEGIC COLLABORATION AIMED AT PRODUCTION OF HALEU NUCLEAR FUEL Source text: ID:nJseW0028a Further company cov
02-23 21:47
UPDATE 2-Bayer proposes $7.25 billion plan to settle Roundup cancer cases
UPDATE 2-Bayer proposes $7.25 billion plan to settle Roundup cancer cases Settlement covers current and future Roundup cancer claims Bayer faces claims from 65,000 plaintiffs over Roundup Supreme Court case could limit Bayer's liability in litigation Updates with information on settlement, litigatio
02-18 03:18
IRadimed targets $100M-plus revenue run rate in 2026 as 3870 pump ramps
Earnings Call Insights: IRADIMED CORPORATION (IRMD) Q4 2025 Management View Roger Susi, Founder, Chairman, CEO & President, began by highlighting "IRadimed achieved its 18th consecutive quarter of rec...
02-11 02:15
iRadimed Raised Its Quarterly Dividend To $0.20/Share From $0.17/Share
IRADIMED CORPORATION (the "Company" or "Iradimed") (NASDAQ:IRMD) announced today its financial results for the quarter and year ended December 31, 2025. The Company is a leader in developing innovative magnetic resonance
02-10 21:08
BRIEF-Mendra Launches With $82M Series A To Acquire, Develop, Commercialize Therapeutics For High Unmet Need Rare Diseases
BRIEF-Mendra Launches With $82M Series A To Acquire, Develop, Commercialize Therapeutics For High Unmet Need Rare Diseases Jan 22 (Reuters) - MENDRA LAUNCHES WITH $82 MILLION SERIES A TO ACQUIRE, DEVELOP, AND COMMERCIALIZE THERAPEUTICS FOR HIGH UNMET NEED RARE DISEASES MENDRA: ROUND WAS CO-LED BY OR
01-22 20:09
BRIEF-E.F. Hutton Advises On Strategic Merger Between Apimeds And Mindwave
Dec 17 (Reuters) - Apimeds Pharmaceuticals US Inc APUS.A: E.F. HUTTON ADVISES ON STRATEGIC MERGER BETWEEN APIMEDS AND MINDWAVE, ALIGNING BIOTECH GROWTH WITH AI-ENABLED FINANCIAL INNOVATION Source text...
2025-12-17 21:27
